While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...

According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

Cross-industry collaboration is key to fighting rising costs for consumers. The Fast Company Impact Council is a private ...

The Galaxy S25 Ultra’s S Pen lacks Bluetooth connectivity and components like a battery. Despite the missing hardware and features, the replacement S Pen costs $50, the same as the previous ...

Humulin R is available in two strengths: U-100, which contains 100 units of insulin ... that you’ll use with insulin syringes 3-mL disposable, prefilled injection pens called a KwikPens Note ...